{
    "physical_examinations": [
        {
            "date": "Not specified",
            "vital_signs": "Not specified",
            "relevant_findings": "Patient 1 showed active moderate-severe Graves' orbitopathy with a clinical activity score (CAS) of 6/10. Patient 2 presented with active moderate-severe Graves' orbitopathy with a CAS of 3/7.",
            "changes_over_time": "In patient 1, after discontinuation of simvastatin and IVGC, normalization of liver enzymes occurred 2 weeks later. In patient 2, liver aminotransferases increased after IVGC, especially three weeks after treatment cessation, with progressive normalization only after statin withdrawal."
        },
        {
            "date": "February 2004",
            "vital_signs": "Not specified",
            "relevant_findings": "Liver function tests normal at baseline. After three IVGC infusions, ALT, GGT, and ALP were elevated (ALT: 79 U/L; GGT: 227 U/L; ALP: 207 U/L).",
            "changes_over_time": "Normal liver function returned within 2 weeks after stopping simvastatin and IVGC. Resumed IVGC without simvastatin showed continued normal liver function."
        },
        {
            "date": "June 2010",
            "vital_signs": "Not specified",
            "relevant_findings": "Normal liver function at baseline. Slight increase in ALT after the fifth IVGC cycle (ALT: 41 U/L).",
            "changes_over_time": "Subsequent increase in ALT (133 U/L) and AST (64 U/L) observed after IVGC discontinuation with further increases noted prior to hospitalization."
        }
    ]
}